This is an old revision of this page, as edited by Greensburger (talk | contribs) at 00:20, 19 September 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 00:20, 19 September 2011 by Greensburger (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| Other names | 3-methyl-2-naphthalene-1,4-dione |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C31H40O2 |
| Molar mass | 444.648 g/mol g·mol |
| (what is this?) (verify) | |
Menatetrenone (INN), also known as MK4, is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis. It is marketed for the latter indication in Japan by Eisai Co., under the trade name Glakay.
Menatetrenone (MK4) is one of the nine forms of vitamin K2.
See also
- Vitamin K
- Phylloquinone (vitamin K1)
References
- Iwamoto J, Takeda T, Sato Y (2006). "Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis". Nutr. Rev. 64 (12): 509–17. doi:10.1111/j.1753-4887.2006.tb00184.x. PMID 17274493.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
External links
- Template:En icon "Glakay" (PDF). Eisai Co. 2005. Retrieved 2007-03-06.
{{cite web}}: Unknown parameter|month=ignored (help) Product information.
| Vitamins (A11) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fat soluble |
| ||||||||
| Water soluble |
| ||||||||
| Combinations | |||||||||
| |||||||||
 | This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |